- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Lupin covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
About Lupin
Lupin is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24100MH1983PLC029442). Business overview includes Pharma (Drug Formulation & Development), incorporated on March 01, 1983 (43+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status. For FY 2024, the company reported revenue of ₹14.77 Kharab with a profit of ₹2.33 Kharab. It has 14 active directors. The company employs approximately 19,688 people.
- Location Kalpataru Inspire, 3Rd Floor, Off Western Express Highway, Santacruz (, Mumbai, Maharashtra - 400055
- Website lupin.com
Financial Performance of Lupin
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,20,083.04 cr | 2,35,431.21 cr | 2,51,890.00 cr | 2,18,400.00 cr | 1,95,200.00 cr | 1,72,000.00 cr | 1,59,000.00 cr |
| Profit/Loss | 13,969.70 cr | 4,810.00 cr | 12,200.00 cr | 9,100.00 cr | -8,200.00 cr | 3,200.00 cr | 5,100.00 cr |
| Cash & Bank Balance | 38,200.00 cr | 35,100.00 cr | 32,000.00 cr | 28,500.00 cr | 25,200.00 cr | 22,000.00 cr | 19,800.00 cr |
| Net Worth | 1,26,731.94 cr | 1,37,500.00 cr | 1,40,200.00 cr | 1,28,000.00 cr | 1,15,000.00 cr | 1,02,000.00 cr | 95,000.00 cr |
| EBITDA | 27,865.49 cr | 29,800.00 cr | 30,200.00 cr | 27,000.00 cr | 24,500.00 cr | 22,000.00 cr | 20,100.00 cr |
Financial Ratios
Values in Crores (Cr) - illustrative trend
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Profit Margin | 10.54 | 3.20 | 2.10 | 1.80 | 0.50 |
| Debt to EBITDA | 2.14 | 1.90 | 1.70 | 1.50 | 1.20 |
| Interest Coverage Ratio | 0.47 | 0.50 | 0.45 | 0.40 | 0.35 |
| Debt to Equity | 0.88 | 0.90 | 0.85 | 0.80 | 0.75 |
| Return on Equity | 12.10 | 3.00 | 2.00 | 1.50 | 0.20 |
| Current Ratio | 1.20 | 1.15 | 1.10 | 1.05 | 0.99 |
| Quick Ratio | 0.95 | 0.92 | 0.88 | 0.85 | 0.80 |
| EBITDA Margin | 12.00 | 10.00 | 8.00 | 7.00 | 5.00 |
| Return on Capital Employed | 8.00 | 2.00 | 1.00 | 0.20 | 0.00 |
| Earning Per Share | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPFO Establishments (1)
Current Directors of Lupin (14)
Charges of Lupin
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 18 Feb 2022
|
100.00 cr | Open |
|
Others
Creation Date: 17 Feb 2022
|
200.00 cr | Open |
|
State Bank Of India
Creation Date: 27 Dec 2021
|
50.00 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Lupin
- Kanwar Bir Singh Anand
- Swaminathan Ramesh
- Ramesh Swaminathan
- Mark Daniel Mc Dade
- Nilesh Deshbandhu Gupta
- Vinita Deshbandhu Gupta
- Punita Lal
- Alfonso Martin Gimenez Zulueta
- Jeffrey Bruce Kindler
- Amit Kumar Gupta
- Manju Deshbandhu Gupta
- Jean Luc Marie Martial Belingard
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.